Skip to content

The effects of Amitriptylline and Tamsulocin on the urinary symtoms of patients with ureteral stent

The effects of Amitriptylline and Tamsulocin on the urinary symtoms of patients with ureteral stent, a randomized clinical trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013041713043N1
Enrollment
210
Registered
2013-05-14
Start date
2013-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Stone. Calculus of Ureter

Interventions

Group1: tamsulosin 0.4 mg once daily for 3 weeks as well as ciprofloxacin 500 mg twice a day Group 2: amitriptyline 25 mg once daily for 3 weeks and tamsulosin 0.4 mg once daily for 3 weeks as well
Treatment - Drugs
Group1: tamsulosin 0.4 mg once daily for 3 weeks as well as ciprofloxacin 500 mg twice a day Group 2: amitriptyline 25 mg once daily for 3 weeks and tamsulosin 0.4 mg once daily for 3 weeks as well

Sponsors

Bushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The patients who have obstruction of upper urinary tract who are candidate for unilateral ureteral stent Exclusion criteria: upper unirary tract infection; urogenital system tumor; history of previous urogenital system surgery; neurogenic bladder; bladder stone; overactive bladder; prostatitis; benign prostatic hyperplasia; pregnancy; age more than 60 years and lower than 20 years old

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Urinary Symptoms. Timepoint: A week and three weeks after intervention. Method of measurement: USSQ questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: A week and three weeks after intervention. Method of measurement: IPSS questionnaire.;Bacterial Colonisation. Timepoint: before intervention and 3 weeks later. Method of measurement: culture.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDarab Moshtaghi

Bushehr University of Medical Sciences

Darabe.20020@yahoo.com+98 77 1252 0657

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026